Cite
MLA Citation
Barbara Klughammer et al.. “Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations.” Journal of thoracic oncology, vol. 11, no. 4, 2016, p. . http://access.bl.uk/ark:/81055/vdc_100031730838.0x00002f